These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32058252)

  • 1. Tailoring of cardiovascular stent material surface by immobilizing exosomes for better pro-endothelialization function.
    Hou YC; Li JA; Zhu SJ; Cao C; Tang JN; Zhang JY; Guan SK
    Colloids Surf B Biointerfaces; 2020 May; 189():110831. PubMed ID: 32058252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilization of nano Cu-MOFs with polydopamine coating for adaptable gasotransmitter generation and copper ion delivery on cardiovascular stents.
    Fan Y; Zhang Y; Zhao Q; Xie Y; Luo R; Yang P; Weng Y
    Biomaterials; 2019 Jun; 204():36-45. PubMed ID: 30875517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An electrospun fiber-covered stent with programmable dual drug release for endothelialization acceleration and lumen stenosis prevention.
    Zhang Y; Wang J; Xiao J; Fang T; Hu N; Li M; Deng L; Cheng Y; Zhu Y; Cui W
    Acta Biomater; 2019 Aug; 94():295-305. PubMed ID: 31195144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents.
    Yang Z; Yang Y; Xiong K; Li X; Qi P; Tu Q; Jing F; Weng Y; Wang J; Huang N
    Biomaterials; 2015 Sep; 63():80-92. PubMed ID: 26093790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
    Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
    Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-endothelialization of nitinol alloy cardiovascular stents enhanced by the programmed assembly of exosomes and endothelial affinity peptide.
    Li L; Yu Y; Sun X; Wang X; Yang X; Yu Q; Kang K; Wu Y; Yi Q
    J Mater Chem B; 2024 May; 12(17):4184-4196. PubMed ID: 38592788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
    Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
    J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Coating Based on Hyaluronic Acid and Dopamine Conjugate for Potential Application on Surface Modification of Cardiovascular Implanted Devices.
    Wu F; Li J; Zhang K; He Z; Yang P; Zou D; Huang N
    ACS Appl Mater Interfaces; 2016 Jan; 8(1):109-21. PubMed ID: 26654689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of electrospun PLLA/PEGDMA polymer coatings for vascular stent material.
    Boodagh P; Guo DJ; Nagiah N; Tan W
    J Biomater Sci Polym Ed; 2016 Aug; 27(11):1086-99. PubMed ID: 27137629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.
    Busch R; Strohbach A; Rethfeldt S; Walz S; Busch M; Petersen S; Felix S; Sternberg K
    Acta Biomater; 2014 Feb; 10(2):688-700. PubMed ID: 24148751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioclickable and mussel adhesive peptide mimics for engineering vascular stent surfaces.
    Yang Z; Zhao X; Hao R; Tu Q; Tian X; Xiao Y; Xiong K; Wang M; Feng Y; Huang N; Pan G
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16127-16137. PubMed ID: 32601214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mussel-inspired catalytic selenocystamine-dopamine coatings for long-term generation of therapeutic gas on cardiovascular stents.
    Yang Z; Yang Y; Zhang L; Xiong K; Li X; Zhang F; Wang J; Zhao X; Huang N
    Biomaterials; 2018 Sep; 178():1-10. PubMed ID: 29902532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic engineering endothelium-like coating on cardiovascular stent through heparin and nitric oxide-generating compound synergistic modification strategy.
    Qiu H; Qi P; Liu J; Yang Y; Tan X; Xiao Y; Maitz MF; Huang N; Yang Z
    Biomaterials; 2019 Jul; 207():10-22. PubMed ID: 30947118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the Biocompatibility of PLLA Stent Materials: Strategy with Biomimetic Coating.
    Du H; Li W; Li X; Qiu Z; Ding J; Zhang Y
    Int J Nanomedicine; 2024; 19():5157-5172. PubMed ID: 38855731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
    Zamani M; Prabhakaran MP; Varshosaz J; Mhaisalkar PS; Ramakrishna S
    Acta Biomater; 2016 Sep; 42():316-328. PubMed ID: 27397493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct surface modification of metallic biomaterials via tyrosine oxidation aiming to accelerate the re-endothelialization of vascular stents.
    Kakinoki S; Takasaki K; Mahara A; Ehashi T; Hirano Y; Yamaoka T
    J Biomed Mater Res A; 2018 Feb; 106(2):491-499. PubMed ID: 28975703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin/poly-l-lysine nanoplatform with growth factor delivery for surface modification of cardiovascular stents: The influence of vascular endothelial growth factor loading.
    Tan J; Cui Y; Zeng Z; Wei L; Li L; Wang H; Hu H; Liu T; Huang N; Chen J; Weng Y
    J Biomed Mater Res A; 2020 Jun; 108(6):1295-1304. PubMed ID: 32064767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring of the dopamine coated surface with VEGF loaded heparin/poly-L-lysine particles for anticoagulation and accelerate in situ endothelialization.
    Liu Y; Zhang J; Wang J; Wang Y; Zeng Z; Liu T; Chen J; Huang N
    J Biomed Mater Res A; 2015 Jun; 103(6):2024-34. PubMed ID: 25256819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-Degradable Drug-Eluting Stent with Anticoagulation, Antiproliferation, and Endothelialization Functions.
    Hou R; Wu L; Wang J; Yang Z; Tu Q; Zhang X; Huang N
    Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.